FGEN

Analyst Sentiment

Wall St. Consensus
Hold
14 analysts·Moderate coverage
55
Score
5 Buy (36%)7 Hold (50%)2 Sell (14%)
Rating Breakdown
Strong Buy
00%
Buy
536%
Hold
750%
Sell
214%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$28.00
+208.7%
Consensus
$28.00
+208.7%
Bull
$28.00
+208.7%
12-Month Target Range14 analysts
$28.00$28.00$28.00
Current $9.07Consensus
Current Price
$9.07
Upside to Consensus
$18.93

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+0.00%
EPS
FY2028
Rev+1.34%
EPS

Earnings Surprises

Recent Analyst Actions

Jun 2, 2023Stifel Nicolaus
Stifel Upgrades FibroGen (FGEN) to Buy
Target:$28.00
+61.7%from $17.32